Glycorex Transplantation Investor Relations Material
Latest events
Q1 2025
23 May, 2025
Q4 2024
27 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Glycorex Transplantation
Access all reports
Glycorex Transplantation is a Swedish biotechnology company that develops and markets medical devices for organ and blood compatibility. The company’s core technology removes specific antibodies from blood, enabling safer organ transplants and transfusions. It serves hospitals and healthcare providers globally. Glycorex Transplantation is headquartered in Lund, Sweden, and its shares are listed on the Spotlight Stock Market.
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
GTAB
Country
🇸🇪 Sweden